These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37479091)

  • 1. Epigenetic regulation of neurotransmitter signaling in neurological disorders.
    Wu T; Cai W; Chen X
    Neurobiol Dis; 2023 Aug; 184():106232. PubMed ID: 37479091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotransmitter transporters in schistosomes: structure, function and prospects for drug discovery.
    Ribeiro P; Patocka N
    Parasitol Int; 2013 Dec; 62(6):629-38. PubMed ID: 23800409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Basis of Lead-Induced Neurological Disorders.
    Wang T; Zhang J; Xu Y
    Int J Environ Res Public Health; 2020 Jul; 17(13):. PubMed ID: 32645824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation and regulation of psychostimulant-sensitive neurotransmitter transporters.
    Vaughan RA
    J Pharmacol Exp Ther; 2004 Jul; 310(1):1-7. PubMed ID: 15064332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotransmitter systems in the etiology of major neurological disorders: Emerging insights and therapeutic implications.
    Nimgampalle M; Chakravarthy H; Sharma S; Shree S; Bhat AR; Pradeepkiran JA; Devanathan V
    Ageing Res Rev; 2023 Aug; 89():101994. PubMed ID: 37385351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic and acute regulation of Na+/Cl- -dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems.
    Zahniser NR; Doolen S
    Pharmacol Ther; 2001 Oct; 92(1):21-55. PubMed ID: 11750035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine: Functions, Signaling, and Association with Neurological Diseases.
    Klein MO; Battagello DS; Cardoso AR; Hauser DN; Bittencourt JC; Correa RG
    Cell Mol Neurobiol; 2019 Jan; 39(1):31-59. PubMed ID: 30446950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environment- and activity-dependent dopamine neurotransmitter plasticity in the adult substantia nigra.
    Aumann TD
    J Chem Neuroanat; 2016 Apr; 73():21-32. PubMed ID: 26718607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of neurotransmitter gamma-aminobutyric acid, glutamate and their receptors.
    Gou ZH; Wang X; Wang W
    Dongwuxue Yanjiu; 2012 Dec; 33(E5-6):E75-81. PubMed ID: 23266985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics and epigenetics in major psychiatric disorders: dilemmas, achievements, applications, and future scope.
    Abdolmaleky HM; Thiagalingam S; Wilcox M
    Am J Pharmacogenomics; 2005; 5(3):149-60. PubMed ID: 15952869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The regulation of glutamic acid decarboxylases in GABA neurotransmission in the brain.
    Lee SE; Lee Y; Lee GH
    Arch Pharm Res; 2019 Dec; 42(12):1031-1039. PubMed ID: 31786745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disturbance of neurotransmitter metabolism in drug-naïve, first-episode major depressive disorder: a comparative study on adult and adolescent cohorts.
    Wang L; Yang P; Yang C; Yang D; Wu X; Cao T; Zeng C; Chen Q; Zhang S; Zhu Z; Jiao S; Cai H
    Eur Arch Psychiatry Clin Neurosci; 2022 Oct; 272(7):1283-1296. PubMed ID: 35410391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotransmitter receptor density changes in Pitx3ak mice--a model relevant to Parkinson's disease.
    Cremer JN; Amunts K; Graw J; Piel M; Rösch F; Zilles K
    Neuroscience; 2015 Jan; 285():11-23. PubMed ID: 25451278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tributyltin enhanced anxiety of adult male zebrafish through elevating cortisol level and disruption in serotonin, dopamine and gamma-aminobutyric acid neurotransmitter pathways.
    Tu X; Li YW; Chen QL; Shen YJ; Liu ZH
    Ecotoxicol Environ Saf; 2020 Oct; 203():111014. PubMed ID: 32888589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental vitamin D deficiency alters multiple neurotransmitter systems in the neonatal rat brain.
    Kesby JP; Turner KM; Alexander S; Eyles DW; McGrath JJ; Burne THJ
    Int J Dev Neurosci; 2017 Nov; 62():1-7. PubMed ID: 28716540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Top 5 Neurotransmitters from a Clinical Neurologist's Perspective.
    Kondziella D
    Neurochem Res; 2017 Jun; 42(6):1767-1771. PubMed ID: 27822666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotransmitter and neurotransmitter receptor expression in the saccule of the human vestibular system.
    Eberhard KE; Kirkeby S; Hansen LJ; Cayé-Thomasen P
    Prog Neurobiol; 2022 May; 212():102238. PubMed ID: 35104536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic dys-regulation of astrocytic glutamate transporter EAAT2 and its implications in neurological disorders and manganese toxicity.
    Karki P; Smith K; Johnson J; Aschner M; Lee EY
    Neurochem Res; 2015 Feb; 40(2):380-8. PubMed ID: 25064045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade and reversal of swimming-induced paralysis in C. elegans by the antipsychotic and D2-type dopamine receptor antagonist azaperone.
    Refai O; Blakely RD
    Neurochem Int; 2019 Feb; 123():59-68. PubMed ID: 29800604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chinese Herbal Medicine Interventions in Neurological Disorder Therapeutics by Regulating Glutamate Signaling.
    Liu Y; Wang S; Kan J; Zhang J; Zhou L; Huang Y; Zhang Y
    Curr Neuropharmacol; 2020; 18(4):260-276. PubMed ID: 31686629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.